SciSparc Ltd.’s stock SPRC was up 74% on Friday, two days after the clinical-stage biopharmaceutical company said it agreed to merge with an unnamed company in Israel. The stock has rallied by about 95% so far this week. SciSparc said Wednesday it agreed to merge with an Israel-based vehicle-import company in the form of a reverse-triangular merger. SciSparc will set up a new wholly-owned Israeli subsidiary, which would in turn merge with and into a target company as the surviving company. SciSparc plans to transfer its technologies and product candidates to a separate legal entity. It will then explore the possible distribution…
Master your money.
Subscribe to MarketWatch.
Get this article and all of MarketWatch.
Access from any device. Anywhere. Anytime.
Subscribe Now
Already a subscriber?
Log In
Read the full article here